We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Clinic First in Italy to Use Innovative Radiotherapy to Treat Head and Neck Cancer

By HospiMedica International staff writers
Posted on 10 Nov 2010
A 54-year-old head and neck cancer patient has become the first person in Italy to be treated using a revolutionary new linear accelerator that can deliver radiotherapy twice as fast as conventional therapy machines. More...


The Humanitas Clinic in Rozzano-Milan (Italy) carried out the treatment in October 2010, becoming only the third hospital in Europe to begin clinical treatments using TrueBeam developed by Varian Medical Systems, Inc. (Palo Alto, CA, USA).

The patient, suffering from cancer of the rhino pharynx, received the required dose of radiotherapy in five treatment sessions using two-arc RapidArc radiotherapy, after which clinicians said his symptoms had alleviated considerably. "We are very satisfied with the progress to date and the patient appears to be responding well,” said Dr. Marta Scorsetti, chief physician at the private clinic.

Dr. Scorsetti reported that the TrueBeam accelerator will be used to treat 50 patients a day and treatments will focus on hypofractionated stereotactic body radiotherapy (SBRT), in particular for liver and pancreatic cancer, non-small-cell lung cancer and lymph-node metastases. "TrueBeam will enable us to offer treatments for different kinds of pathologies than have previously been possible with radiosurgery here at Humanitas,” said Dr. Scorsetti. "In particular we will be able to treat patients with previously treated recurrences which could not have been re-treated otherwise.”

According to Dr. Scorsetti, total bone marrow irradiation (TMI) is a good example of an innovative radiotherapy treatment made possible by TrueBeam. "We can provide fast total marrow irradiation with excellent quality using TrueBeam,” she said, adding that clinicians at Humanitas intend to commence such treatments in November 2010, using the TrueBeam device to deliver RapidArc with eight arcs and four isocenters. TMI is carried out during the treatment of multiple myeloma, a cancer of plasma cells.

Dr. Scorsetti noted that TrueBeam has many new features that will enable her to offer cancer patients more advanced care. Developed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, the TrueBeam platform for image-guided radiotherapy and radiosurgery was introduced by Varian in April 2010 as the first fully-integrated system designed from the ground up to treat a moving target with unprecedented speed and accuracy. RapidArc delivers a volumetric intensity-modulated radiation therapy (IMRT) treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided IMRT two to eight times faster than is possible with traditional IMRT.

Related Links:
Varian Medical Systems



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.